These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 26390158)

  • 41. CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches.
    Tang J; Zheng Q; Wang Q; Zhao Y; Ananthanarayanan P; Reina C; Šabanović B; Jiang K; Yang MH; Meny CC; Wang H; Agerbaek MØ; Clausen TM; Gustavsson T; Wen C; Borghi F; Mellano A; Fenocchio E; Gregorc V; Sapino A; Theander TG; Fu D; Aicher A; Salanti A; Shen B; Heeschen C
    Cell Rep Med; 2024 Sep; 5(9):101692. PubMed ID: 39163864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating tumor cells in pancreatic cancer patients: methods of detection and clinical implications.
    Tjensvoll K; Nordgård O; Smaaland R
    Int J Cancer; 2014 Jan; 134(1):1-8. PubMed ID: 23447365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating tumor cells in pancreatic cancer patients: enrichment and cultivation.
    Bobek V; Gurlich R; Eliasova P; Kolostova K
    World J Gastroenterol; 2014 Dec; 20(45):17163-70. PubMed ID: 25493031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating Tumor Cells: State-of-the-art Update on Technologies and Clinical Applications.
    Yap K; Cohen EN; Reuben JM; Khoury JD
    Curr Hematol Malig Rep; 2019 Oct; 14(5):353-357. PubMed ID: 31364034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
    Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K
    World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reviews on Current Liquid Biopsy for Detection and Management of Pancreatic Cancers.
    Kaczor-Urbanowicz KE; Cheng J; King JC; Sedarat A; Pandol SJ; Farrell JJ; Wong DTW; Kim Y
    Pancreas; 2020 Oct; 49(9):1141-1152. PubMed ID: 33003085
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation.
    Wang K; Wang X; Pan Q; Zhao B
    Mol Cancer; 2023 Oct; 22(1):167. PubMed ID: 37803304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aptamer-Based Methods for Detection of Circulating Tumor Cells and Their Potential for Personalized Diagnostics.
    Zamay AS; Zamay GS; Kolovskaya OS; Zamay TN; Berezovski MV
    Adv Exp Med Biol; 2017; 994():67-81. PubMed ID: 28560668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single circulating tumor cell sequencing as an advanced tool in cancer management.
    Salvianti F; Pazzagli M; Pinzani P
    Expert Rev Mol Diagn; 2016; 16(1):51-63. PubMed ID: 26560087
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coupled liquid biopsy and bioinformatics for pancreatic cancer early detection and precision prognostication.
    Hou J; Li X; Xie KP
    Mol Cancer; 2021 Feb; 20(1):34. PubMed ID: 33593396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liquid biopsies for management of pancreatic cancer.
    Samandari M; Julia MG; Rice A; Chronopoulos A; Del Rio Hernandez AE
    Transl Res; 2018 Nov; 201():98-127. PubMed ID: 30118658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular analysis of circulating tumors cells: Biomarkers beyond enumeration.
    Hwang WL; Pleskow HM; Miyamoto DT
    Adv Drug Deliv Rev; 2018 Feb; 125():122-131. PubMed ID: 29326053
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating tumor cells in lung cancer.
    Young R; Pailler E; Billiot F; Drusch F; Barthelemy A; Oulhen M; Besse B; Soria JC; Farace F; Vielh P
    Acta Cytol; 2012; 56(6):655-60. PubMed ID: 23207444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biological and Molecular Characterization of Circulating Tumor Cells: A Creative Strategy for Precision Medicine?
    Chen S; El-Heliebi A; Kroneis T
    Adv Clin Chem; 2017; 82():71-103. PubMed ID: 28939214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CTCs in early breast cancer: A path worth taking.
    Maltoni R; Gallerani G; Fici P; Rocca A; Fabbri F
    Cancer Lett; 2016 Jul; 376(2):205-10. PubMed ID: 27060205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
    Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
    PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of liquid biopsy in precision medicine: opportunities and challenges.
    Wang J; Chang S; Li G; Sun Y
    Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Opportunities and Challenges for Pancreatic Circulating Tumor Cells.
    Nagrath S; Jack RM; Sahai V; Simeone DM
    Gastroenterology; 2016 Sep; 151(3):412-26. PubMed ID: 27339829
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of single circulating tumor cells.
    Alix-Panabières C; Pantel K
    FEBS Lett; 2017 Aug; 591(15):2241-2250. PubMed ID: 28459503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating Tumor Cells in Diagnosis and Treatment of Lung Cancer.
    Maly V; Maly O; Kolostova K; Bobek V
    In Vivo; 2019; 33(4):1027-1037. PubMed ID: 31280190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.